Funding for this research was provided by:
Instituto de Salud Carlos III (PIE15/00068, PI16/00354, PI17/01865)
Comunidad de Madrid (B2017/BMD3733)
Ministerio de Economía y Competitividad (SAF2017-83732-R)
Received: 15 June 2020
Accepted: 25 October 2020
First Online: 11 November 2020
Ethics approval and consent to participate
: Ethics approval was obtained from the Madrid Regional Government Ethics Board for Drug Research and the Spanish Agency for Medicine and Health Products (AEMPS).All participants gave informed consent to participate before taking part of the study.
: Not applicable.
: MQF has received research funds from Astra Zeneca. MQF has received a Research Award from Astra Zeneca Foundation (“Jovenes Investigadores – Cancer 2016”).